美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

艾格里房產

79.05

+1.091.40%

盤後：78.59-0.4635-0.59%19:15 EDT

成交量：114.62萬

成交額：9,064.02萬

市值：84.69億

市盈率：44.41

高：79.61

開：78.00

低：78.00

收：77.96

資料載入中...

總覽公司新聞公告

Agree Realty Corp 預計每股收益 42 美分 - 財報前瞻

第 12 項！默沙東啓動科倫博泰 TROP2 ADC III 期臨牀試驗

Insight数据库

股海導航_2025年4月17日_滬深股市公告與交易提示

“ADC新星”上市首日大漲超100%，市值突破170億港元

国际金融报

輝瑞、禮來新適應症在華報產！康弘Trop2-ADC嶄露頭角

医药经济报

創下2022年以來18A融資規模新紀錄，ADC獨角獸映恩生物-B(09606)強勢登陸港股

智通财经网

CD38單抗破局，如何重塑多發性骨髓瘤治療版圖？｜21CC腫瘤周

21世纪经济报道

中國ADC的泡沫正在破裂

映恩生物登陸港交所首日大漲116.70%；百利天恆第10款ADC獲批臨牀試驗 | 醫藥早參

每日经济新闻

上市首日，暴漲116%！

中国基金报

頭部ADC藥企港股上市，首日股價大漲

【百利天恆：BL-B01D1（EGFR×HER3 雙抗 ADC）聯合用藥治療多種晚期實體瘤獲 4 個 II 期藥物臨牀試驗批准通知書】金融界4月15日消息，百利天恆近日收到國家藥品監督管理局正式批准簽發的 4 個《藥物臨牀試驗批准通知書》，公司自主研發的創新生物藥注射用 BL-B01D1（EGFR×HER3 雙抗 ADC）的 4 個聯合用藥的 II 期臨牀試驗獲得批准。注射用 BL-B01D1 臨牀試驗符合藥品註冊要求，同意開展聯合侖伐替尼用於晚期肝癌、聯合阿昔替尼±帕博利珠單抗用於晚期腎癌、聯合貝伐珠單抗±化療用於晚期結直腸癌、聯合帕博利珠單抗±化療用於晚期膽道惡性腫瘤的臨牀試驗。BL-B01D1 是全球首創且唯一進入 III 期臨牀階段的 EGFR×HER3 雙抗 ADC，除本次新批准的 4 項臨牀試驗外，正在中國和美國進行 30 餘項針對十餘種腫瘤類型的臨牀試驗。藥品需完成相關臨牀試驗並通過審評、審批後方可上市銷售，醫藥產品具有諸多特點，從研究到投產環節多，易受不確定性因素影響。

【新股IPO】映恩生物(09606) 佈局ADC領域全球化商業模式首日盤中暴漲

當乳腺癌診療邂逅AI，中國能否率先叩開精準智能均質時代大門？

ADC明星企業映恩生物登陸港交所，盤中漲幅高達116.7%

暴漲130%！映恩生物正式登陸港交所，市值超181億港元，抗體偶聯藥物ADC領域全球領跑者

【映恩生物高開超90% 昨日暗盤迎來大漲】截至發稿，映恩生物(09606.HK)漲91.33%。消息方面，該公司在昨日的暗盤大漲87.1%。根據公開資料，映恩生物是一家專注於新一代抗體偶聯藥物研發的創新生物製藥企業，致力於爲癌症和自身免疫性疾病等患者研發新一代ADC創新藥物。

新股首日 | 映恩生物-B(09606)首掛上市早盤高開91.33% 公司為ADC創新藥物研發商

藥明生物斬獲五項亞太生物工藝卓越獎

火爆！18A最大IPO誕生！映恩生物創ADC港股神話

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ADC/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADC\",,,,,undefined,":{"symbol":"ADC","market":"US","secType":"STK","nameCN":"艾格里房產","latestPrice":79.05,"timestamp":1744920000000,"preClose":77.96,"halted":0,"volume":1146210,"hourTrading":{"tag":"盘后","latestPrice":78.5865,"preClose":79.05,"latestTime":"19:15 EDT","volume":24750,"amount":1956417.696,"timestamp":1744931714100},"delay":0,"floatShares":105055129,"shares":107134634,"eps":1.779999,"marketStatus":"休市中","change":1.09,"latestTime":"04-17 16:00:00 EDT","open":78,"high":79.61,"low":78,"amount":90640173.18876001,"amplitude":0.020652,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.779999,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":766296000000,"exchange":"NYSE","adjPreClose":77.96,"dividendRate":0.037951,"preHourTrading":{"tag":"盘前","latestPrice":77.9,"preClose":77.96,"latestTime":"08:44 EDT","volume":261,"amount":20281.884570000002,"timestamp":1744893847283},"postHourTrading":{"tag":"盘后","latestPrice":78.5865,"preClose":79.05,"latestTime":"19:15 EDT","volume":24750,"amount":1956417.696,"timestamp":1744931714100},"volumeRatio":0.8182819732702872,"impliedVol":0.2584,"impliedVolPercentile":0.8685},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADC\",,,,,undefined,":{"symbol":"ADC","floatShares":105055129,"roa":"2.29%","roe":"3.54%","lyrEps":1.793039,"volumeRatio":0.8182819732702872,"shares":107134634,"dividePrice":3,"high":79.61,"amplitude":0.020652,"preClose":77.96,"low":78,"week52Low":55.05,"pbRate":"1.59","psRate":"13.72","week52High":79.61,"institutionHeld":0.8991,"latestPrice":79.05,"eps":1.779999,"divideRate":0.037951,"volume":1146210,"delay":0,"ttmEps":1.779999,"open":78,"prevYearClose":70.45,"prevWeekClose":74.91,"prevMonthClose":77.19,"prevQuarterClose":77.19,"fiveDayClose":72.95,"twentyDayClose":76.26,"sixtyDayClose":71.5,"earningDate":1745251200000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADC\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528011992","title":"Agree Realty Corp 預計每股收益 42 美分 - 財報前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2528011992","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528011992?lang=zh_tw&edition=fundamental","pubTime":"2025-04-19 04:41","pubTimestamp":1745008871,"startTime":"0","endTime":"0","summary":"Agree Realty Corp 预计每股收益 42 美分 - 财报前瞻Agree Realty Corp ADC.N, ADC将于4月22日公布截至3月31日的财报，预计季度收入将有所增长。LSEG 分析师对 Agree Realty Corp 的平均预期为每股收益 42 美分。华尔街对 Agree Realty Corp 的 12 个月目标价中位数为 81.00 美元，高于其最新收盘价 79.05 美元。4月18日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250418:nL4S3QW0P6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC"],"gpt_icon":0},{"id":"2528595000","title":"第 12 項！默沙東啓動科倫博泰 TROP2 ADC III 期臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2528595000","media":"Insight数据库","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528595000?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 17:23","pubTimestamp":1744968229,"startTime":"0","endTime":"0","summary":"4 月 18 日，中国药物临床试验登记与信息公示平台显示，默沙东登记了一项比较 Sac-TMT联合/不联合帕博利珠单抗与 TPC一线治疗不可切除/转移性三阴性乳腺癌的 III 期研究。Insight 数据库显示，这是默沙东针对该药启动的第 12 项全球多中心临床试验。该药首次于 2024 年 11 月获 NMPA 批准上市，用于三阴性乳腺癌的二线治疗。2022 年 5 月，科伦博泰与默沙东签署合作协议，授予后者在大中华区以外的所有地区开发、使用、制造及商业化Sac-TMT 的独家权利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418172807a6bf22a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418172807a6bf22a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1116320901.HKD","LU0965509101.SGD","LU1057294990.SGD","SG9999013999.USD","IE0009355771.USD","LU1093756325.SGD","BK4550","LU1037948897.HKD","SG9999001176.SGD","IE00B4R5TH58.HKD","ADC","BK4585","LU1066051498.USD","LU0965509010.AUD","LU0965509283.SGD","IE0002141913.USD","LU1941712348.USD","IE00BJJMRZ35.SGD","LU1116320737.USD","LU0058720904.USD","SG9999015358.SGD","SG9999015341.SGD","LU0965508806.USD","LU1974910355.USD","LU0320765489.SGD","BK4559","LU1430594728.SGD","MRK","SG9999014559.SGD","BK4588","BK4080","BK4533","III","LU1699723380.USD","IE00BFTCPJ56.SGD","BK4534","LU0266013472.USD","LU1989772840.SGD","LU0006306889.USD","SG9999014542.SGD","SG9999014567.USD","LU0289739699.SGD","LU0985320562.USD","LU1066053197.SGD","BK4134","LU1929549753.HKD","LU2324357040.USD","LU1983299246.USD","LU1989771016.USD","SGXZ57979304.SGD"],"gpt_icon":0},{"id":"2528785487","title":"股海導航_2025年4月17日_滬深股市公告與交易提示","url":"https://stock-news.laohu8.com/highlight/detail?id=2528785487","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528785487?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 08:34","pubTimestamp":1744850040,"startTime":"0","endTime":"0","summary":"　　3连板国光连锁：滚动市盈率为467.85倍 明显高于行业平均值。　　九联科技：筹划收购能通科技51%股份。　　蓝科高新：拟收购蓝亚检测100%股权和中国空分51%股权。　　厦门象屿：拟回购1亿股至1.5亿股公司股份。　　常青股份：拟3000万元—5000万元回购股份。　　中信博：2024年净利润同比增长83.03% 拟10派10元。　　冰轮环境：2024年净利润同比下降4.76% 拟10转3派1.5元。　　神宇股份：以2241万元竞得江阴市一地块","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2025-04-17/doc-inetmqqf3772260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ADC","BK4231","BK4080"],"gpt_icon":0},{"id":"2527300218","title":"“ADC新星”上市首日大漲超100%，市值突破170億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527300218","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527300218?lang=zh_tw&edition=fundamental","pubTime":"2025-04-16 19:34","pubTimestamp":1744803287,"startTime":"0","endTime":"0","summary":"4月15日，生物医药行业备受瞩目的抗体偶联药物（ADC）新星映恩生物终于正式亮相资本市场，于港交所主板挂牌上市，股票代码HK9606.截至收盘，公司股价报收205港元/股，大涨116.7%，总市值突破170亿港元。另据发售公告，映恩生物本次香港公开发售获115.14倍的超额认购，国际配售获13.52倍认购，最终发售价为每股94.6港元，全球发售净筹约15.13亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504163378847959.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504163378847959.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ADC","BK4080","BK4231"],"gpt_icon":0},{"id":"2527297956","title":"輝瑞、禮來新適應症在華報產！康弘Trop2-ADC嶄露頭角","url":"https://stock-news.laohu8.com/highlight/detail?id=2527297956","media":"医药经济报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527297956?lang=zh_tw&edition=fundamental","pubTime":"2025-04-16 19:06","pubTimestamp":1744801572,"startTime":"0","endTime":"0","summary":"辉瑞 PARP 抑制剂新适应症在华申报上市今日，CDE官网显示，辉瑞制药的甲苯磺酸他拉唑帕利胶囊新适应症上市申请获受理。根据注册分类以及临床试验进展推测，此次申报的适应症为胚系 BRCA突变的HER2阴性乳腺癌。根据公开资料推测，本次该药申报上市的适应症为治疗中重度活动性溃疡性结肠炎成人患者。根据礼来此前新闻稿，这是首个用于治疗这一患者群体的IL-23p19拮抗剂。此外，礼来已于2024年10月公布了多年期的Ⅲ期试验结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416191552a6bc81e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416191552a6bc81e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LLY","LU1974910355.USD","LU1894683264.USD","LU2750360641.GBP","LU0689472784.USD","LU2471134523.USD","LU0114720955.EUR","SG9999015986.USD","LU0985481810.HKD","LU1720051017.SGD","LU2552382132.HKD","LU2237443382.USD","LU0823416689.USD","BK4599","LU0385154629.USD","LU1868837136.USD","LU2491049909.HKD","LU0058720904.USD","LU0122379950.USD","SG9999017495.SGD","SGXZ99366536.SGD","LU0943347566.SGD","LU2211815571.USD","LU0882574139.USD","LU1868837300.USD","LU0417517546.SGD","ADC","LU0672654240.SGD","LU1917777945.USD","LU0234572021.USD","LU1232071149.USD","IE00BJT1NW94.SGD","IE00BBT3K403.USD","LU0354030511.USD","LU1548497426.USD","LU1894683348.USD","LU1868836757.USD","LU2361045086.USD","LU2468319806.SGD","LU1057294990.SGD","SG9999018857.SGD","IE0002270589.USD","LU2237443549.SGD","LU0256863902.USD","PFE","SG9999014906.USD","LU2361044865.SGD","SG9999014898.SGD","LU0868494617.USD","LU0456855351.SGD"],"gpt_icon":1},{"id":"2527534280","title":"創下2022年以來18A融資規模新紀錄，ADC獨角獸映恩生物-B(09606)強勢登陸港股","url":"https://stock-news.laohu8.com/highlight/detail?id=2527534280","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527534280?lang=zh_tw&edition=fundamental","pubTime":"2025-04-16 12:09","pubTimestamp":1744776596,"startTime":"0","endTime":"0","summary":"坐拥自2022年以来18A生物科技板块内最大融资规模，暂居2025年港股IPO首日涨幅榜榜首......映恩生物-B凭借上述成绩，完成了从“国内ADC黑马”向“港股18A明星标的”的华丽转身。自2023年以来，映恩生物先后与BioNTech、百济神州、Adcendo、GSK、Avenzo、三生制药等国内外顶尖药企达成多项BD交易，总价值超60亿美元，助力公司成为国产ADC独角兽与出海“生力军”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1279367.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["HSTECH","BK4080","YANG","BK4614","ADC","BK4231","09606"],"gpt_icon":1},{"id":"2527285130","title":"CD38單抗破局，如何重塑多發性骨髓瘤治療版圖？｜21CC腫瘤周","url":"https://stock-news.laohu8.com/highlight/detail?id=2527285130","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527285130?lang=zh_tw&edition=fundamental","pubTime":"2025-04-16 09:24","pubTimestamp":1744766662,"startTime":"0","endTime":"0","summary":"编者按：2025年4月15日—21日是第31个全国肿瘤防治宣传周，今年宣传主题为“科学防癌健康生活”，旨在通过普及癌症防治科学知识，倡导群众践行健康生活方式，控制癌症风险因素；鼓励高风险人群主动参加癌症筛查，促进早诊早治；指导癌症患者及时接受规范化诊疗，并定期复查。通过全过程全生命周期健康管理，更好满足人民群众健康需求，保障人民群众健康生活。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504163378198872.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504163378198872.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4080","BK4020","LU0942090050.USD","LU1430594728.SGD","IE00BGHQF631.EUR","LU1066053197.SGD","IE00BFMHRM44.USD","LU1235294995.USD","LU1571399168.USD","LU1585245621.USD","LU1823568750.SGD","SG9999002232.USD","SG9999015945.SGD","LU1880398554.USD","LU1059921491.USD","LU0234572021.USD","ADC","BK4581","IE00B42XCP33.USD","LU0731783394.SGD","LU2237443549.SGD","LU0792757196.USD","SG9999015952.SGD","BK4585","PFS","SG9999015986.USD","LU1883839398.USD","LU0203347892.USD","BK4560","IE00BFXG1179.USD","CSCO","LU2237443978.SGD","LU2506952097.USD","LU1046421795.USD","SG9999002224.SGD","BK4211","IE00BKVL7J92.USD","BK4525","LU2237443382.USD","LU2237443465.HKD","LU2237443622.USD","LU2247934214.USD","LU2506951875.HKD","LU1244550577.SGD","LU0823417737.USD","LU1894683348.USD","BK4550","LU1066051811.HKD","BK4195","LU0234570918.USD"],"gpt_icon":0},{"id":"2527470477","title":"中國ADC的泡沫正在破裂","url":"https://stock-news.laohu8.com/highlight/detail?id=2527470477","media":"医曜","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527470477?lang=zh_tw&edition=fundamental","pubTime":"2025-04-16 07:40","pubTimestamp":1744760442,"startTime":"0","endTime":"0","summary":"随着热度降温，资本也开始变得理性，不少ADC企业遭遇融资困难、现金流告急，部分药企更是无奈砍掉ADC管线，中国ADC行业泡沫的裂痕初现。据统计，国产ADC新药研发达到惊人的500多项，大概占全球管线的40%。但实际上，ADC药物的技术门槛被集体低估。事实上，EO-3021并非首个被“终止”的中国Claudin 18.2 ADC。核心人员何如意离职，其首个国产ADC药物维迪西妥单抗，在辉瑞收购Seagen后，在2024年被辉瑞计提2亿元无形资产减值。除此之外，诸多国内ADC项目接连受挫。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8iZf4SnjwIn","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["BK4231","ADC","BK4080"],"gpt_icon":0},{"id":"2527477255","title":"映恩生物登陸港交所首日大漲116.70%；百利天恆第10款ADC獲批臨牀試驗 | 醫藥早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2527477255","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527477255?lang=zh_tw&edition=fundamental","pubTime":"2025-04-16 07:40","pubTimestamp":1744760413,"startTime":"0","endTime":"0","summary":"NO.1映恩生物登陆港交所首日大涨116.70%4月15日，映恩生物正式在港交所挂牌，截至收盘股价大涨116.70%。公司本次IPO（首次公开发行）认购募资总额为2.1亿美元，约合人民币15.4亿元，刷新了2022年以来港股18A生物科技公司的融资纪录。资料显示，映恩生物成立于2019年，主要研发创新抗体偶联药物（ADC），用于治疗癌症、自身免疫性疾病等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504163377896945.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504163377896945.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["03347","ADC","BK1515","BK1574","BK1583","09939","BK4231","BK1161","BK1141","09606","BK4080","BK1576"],"gpt_icon":1},{"id":"2527541871","title":"上市首日，暴漲116%！","url":"https://stock-news.laohu8.com/highlight/detail?id=2527541871","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527541871?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 19:27","pubTimestamp":1744716420,"startTime":"0","endTime":"0","summary":"一新股上市首日暴涨116%！截至收盘，恒生指数涨0.23%，报21466.27点；恒生科技指数跌0.67%，报4981.60点；恒生国企指数涨0.21%，报7982.88点。上市首日暴涨116%4月15日，生物医药股映恩生物-B获115.14倍认购，上市首日暴涨116.7%！其中多项临床阶段的ADC，在17个国家230多个临床试验中心开展7项全球临床试验，已入组超过2000名患者，50%患者来自海外。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2025-04-15/doc-inethcvn8210182.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-04-15/doc-inethcvn8210182.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4080","BK4231","ADC"],"gpt_icon":0},{"id":"2527995244","title":"頭部ADC藥企港股上市，首日股價大漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2527995244","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527995244?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 18:27","pubTimestamp":1744712820,"startTime":"0","endTime":"0","summary":"4月15日，映恩生物在中国香港上市首日股价上涨130%，总市值达到约180亿港元。映恩生物的招股书显示，该公司正在开发用于治疗癌症和自身免疫性疾病的药物。截至目前，映恩生物累计对外授权交易金额超60亿美元，也是国内ADC药物对外授权的头部初创公司。映恩生物在港股上市，也有望进一步推动港股生物科技公司的繁荣。今年以来，港股上市的生物医药股今年以来也已大幅上涨。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2025-04-15/doc-inetfxpw1071955.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-04-15/doc-inetfxpw1071955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HSTECH","BK4080","07226","BK4614","ADC","BK4231","YANG"],"gpt_icon":1},{"id":"2527464947","title":"【百利天恆：BL-B01D1（EGFR×HER3 雙抗 ADC）聯合用藥治療多種晚期實體瘤獲 4 個 II 期藥物臨牀試驗批准通知書】金融界4月15日消息，百利天恆近日收到國家藥品監督管理局正式批准簽發的 4 個《藥物臨牀試驗批准通知書》，公司自主研發的創新生物藥注射用 BL-B01D1（EGFR×HER3 雙抗 ADC）的 4 個聯合用藥的 II 期臨牀試驗獲得批准。注射用 BL-B01D1 臨牀試驗符合藥品註冊要求，同意開展聯合侖伐替尼用於晚期肝癌、聯合阿昔替尼±帕博利珠單抗用於晚期腎癌、聯合貝伐珠單抗±化療用於晚期結直腸癌、聯合帕博利珠單抗±化療用於晚期膽道惡性腫瘤的臨牀試驗。BL-B01D1 是全球首創且唯一進入 III 期臨牀階段的 EGFR×HER3 雙抗 ADC，除本次新批准的 4 項臨牀試驗外，正在中國和美國進行 30 餘項針對十餘種腫瘤類型的臨牀試驗。藥品需完成相關臨牀試驗並通過審評、審批後方可上市銷售，醫藥產品具有諸多特點，從研究到投產環節多，易受不確定性因素影響。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527464947","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527464947?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 17:25","pubTimestamp":1744709155,"startTime":"0","endTime":"0","summary":"金融界4月15日消息，百利天恒近日收到国家药品监督管理局正式批准签发的 4 个《药物临床试验批准通知书》，公司自主研发的创新生物药注射用 BL-B01D1 的 4 个联合用药的 II 期临床试验获得批准。BL-B01D1 是全球首创且唯一进入 III 期临床阶段的 EGFR×HER3 双抗 ADC，除本次新批准的 4 项临床试验外，正在中国和美国进行 30 余项针对十余种肿瘤类型的临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/15172549549379.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1141","BK0239","III","BK1583","09939","BK1576","159938","BK1515","BK1161","BK4134","03347","BK4023","BL","LU1815336091.USD","ADC","159839","LU0757428866.USD","688506","BK4231","BK4080","BK1574"],"gpt_icon":0},{"id":"2527883364","title":"【新股IPO】映恩生物(09606) 佈局ADC領域全球化商業模式  首日盤中暴漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2527883364","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527883364?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 11:13","pubTimestamp":1744686831,"startTime":"0","endTime":"0","summary":"金吾财讯|映恩生物(09606)上市首日盘中暴涨，最高至132.56%，每股222港元。早盘持续高位，截止发稿报208.8港元，涨幅达120.72%。昨日暗盘收盘亦大涨87.10%，报177.00港元，不计手续费，每手赚8240港元。据悉，映恩生物在ADC领域的全球化商业模式取得了显著的成效。从技术平台的构建到研发管线的布局，从全球授权合作到全球临床协同，映恩生物形成了一个完整的全球化商业闭环。已先后与BioNTech、百济神州、葛兰素史克、Avenzo等国际知名药企达成授权出海合作，交易总金额超过60亿美元，其中已经收到的预付款和商业化里程碑约5亿美元。","market":"sg","thumbnail":"https://static.szfiu.com/news/20220324/OWMzMDQ5MTY2NDM3ODU0ODM5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20220324/OWMzMDQ5MTY2NDM3ODU0ODM5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5297752f2e4ee415e69380642a004984","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1957215","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606","BK4231","BK4080","ADC"],"gpt_icon":0},{"id":"2527102958","title":"當乳腺癌診療邂逅AI，中國能否率先叩開精準智能均質時代大門？","url":"https://stock-news.laohu8.com/highlight/detail?id=2527102958","media":"环球网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527102958?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 10:47","pubTimestamp":1744685233,"startTime":"0","endTime":"0","summary":"“乳腺癌诊疗正迈向精准化、智能化的新阶段，此次发布的三大成果将为中国乳腺癌规范化诊疗注入强劲动力，引领诊疗新时代。”此次大会，正式发布了《CSCO乳腺癌诊疗指南2025》《中国乳腺癌诊疗指南2025》及全新升级的CSCO AI Pro人工智能辅助决策系统三大核心成果。作为大会的重头戏之一，《CSCO乳腺癌诊疗指南2025》于4月11日下午正式发布，并同步启动了全国巡讲计划。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.huanqiu.com/article/4MHfAOpL0ed","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_huanqiu","symbols":["IE00BVYPNW00.USD","ADC","LU1430594728.SGD","BK4527","LU2247934214.USD","BK4550","CSCO","LU2237443465.HKD","LU2506952170.USD","LU1894683264.USD","LU0889566641.SGD","LU1235294995.USD","BK4020","IE00BVYPNV92.GBP","LU0731783394.SGD","IE00B42XCP33.USD","LU0942090050.USD","LU1066051225.USD","BK4585","LU0950375773.USD","IE00BZ1G4Q59.USD","LU0823417737.USD","LU2506951958.HKD","SG9999015986.USD","LU2506951875.HKD","LU0868494708.USD","LU1066053197.SGD","BK4525","IE00BGHQF631.EUR","BK4515","LU1059921491.USD","BK4560","LU0234570918.USD","LU0348723411.USD","LU0203347892.USD","LU1880398471.USD","BK4588","LU0792757196.USD","LU2506952097.USD","LU1823568750.SGD","LU1585245621.USD","SG9999002232.USD","IE00B3T34201.USD","LU1066051498.USD","SG9999001424.SGD","LU1894683348.USD","IE00BDGV0183.EUR","IE00B3PB1722.GBP","LU1571399168.USD","LU2237443978.SGD"],"gpt_icon":0},{"id":"2527410652","title":"ADC明星企業映恩生物登陸港交所，盤中漲幅高達116.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527410652","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527410652?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 10:10","pubTimestamp":1744683017,"startTime":"0","endTime":"0","summary":"4月15日，ADC明星企业映恩生物-B（09606.HK）正式登陆港交所。截至发稿，映恩生物报205港元/股，涨幅116.7%。映恩生物IPO发行定价为94.6港元/股，认购情况火爆，募资总额约2.1亿美元（约合人民币15.4亿元），这是自2022年来募资规模最大的港股18A企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5297752f2e4ee415e69380642a004984","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504153377128371.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09606","BK4080","ADC","BK4231"],"gpt_icon":0},{"id":"2527102312","title":"暴漲130%！映恩生物正式登陸港交所，市值超181億港元，抗體偶聯藥物ADC領域全球領跑者","url":"https://stock-news.laohu8.com/highlight/detail?id=2527102312","media":"市场资讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527102312?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 09:52","pubTimestamp":1744681920,"startTime":"0","endTime":"0","summary":"　　映恩生物-B今日成功在港交所主板上市，Morgan Stanley、Jefferies以及CITIC Securities为联席保荐人。　　映恩生物是全球抗体偶联药物领域的关键领跑者，致力于为癌症和自身免疫性疾病等患者研发ADC创新药物。　　公司拥有自主研发的两款核心产品，即DB-1303/BNT323及DB-1311/BNT324。　　今日开盘，映恩生物涨130.44%，报218.00港元/股，市值181.32亿港元。　　截至2月19日，公司尚未获得任何候选药物的上市批准，亦未从产品销售中获得任何收入。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-04-15/doc-inetfhrt7419875.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4231","ADC","09606","BK4080"],"gpt_icon":1},{"id":"2527628177","title":"【映恩生物高開超90% 昨日暗盤迎來大漲】截至發稿，映恩生物(09606.HK)漲91.33%。消息方面，該公司在昨日的暗盤大漲87.1%。根據公開資料，映恩生物是一家專注於新一代抗體偶聯藥物研發的創新生物製藥企業，致力於爲癌症和自身免疫性疾病等患者研發新一代ADC創新藥物。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527628177","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527628177?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 09:27","pubTimestamp":1744680474,"startTime":"0","endTime":"0","summary":"截至发稿，映恩生物(09606.HK)涨91.33%。消息方面，该公司在昨日的暗盘大涨87.1%。根据公开资料，映恩生物是一家专注于新一代抗体偶联药物研发的创新生物制药企业，致力于为癌症和自身免疫性疾病等患者研发新一代ADC创新药物。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5297752f2e4ee415e69380642a004984","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/15092749540314.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["09606","BK4080","BK4231","159992","BK1574","ADC","06978","BK1161"],"gpt_icon":0},{"id":"2527177835","title":"新股首日 | 映恩生物-B(09606)首掛上市 早盤高開91.33% 公司為ADC創新藥物研發商","url":"https://stock-news.laohu8.com/highlight/detail?id=2527177835","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527177835?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 09:21","pubTimestamp":1744680097,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，映恩生物-B首挂上市，公告显示，每股定价94.6港元，共发行1733.23万股股份，每手100股，所得款项净额约15.13亿港元。截至发稿，涨91.33%，报181港元，成交额7.82亿港元。公开资料显示，映恩生物于2020年正式运营，是抗体偶联药物领域的全球领跑者。其中多项临床阶段的ADC，在17个国家230多个临床试验中心开展7项全球临床试验，已入组超过2000多名患者，50%患者来自海外。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5297752f2e4ee415e69380642a004984","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1278631.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09606","BK4080","BK4231","159992","BK1574","ADC","06978","BK1161"],"gpt_icon":1},{"id":"2527019458","title":"藥明生物斬獲五項亞太生物工藝卓越獎","url":"https://stock-news.laohu8.com/highlight/detail?id=2527019458","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527019458?lang=zh_tw&edition=fundamental","pubTime":"2025-04-14 21:08","pubTimestamp":1744636080,"startTime":"0","endTime":"0","summary":"药明生物首席执行官陈智胜博士表示：\"此次药明生物斩获的多项荣誉有力地证明了我们为全球客户和生物制药行业提供的价值。药明生物在中国、美国、爱尔兰、德国和新加坡拥有超过12000名员工。截至2024年12月底，药明生物帮助客户研发和生产的综合项目高达817个，其中包括21个商业化生产项目。药明生物以可持续发展为长期业务增长的基石。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4663759_ZH63759_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU0823426308.USD","BK4195","BK4533","LU0052750758.USD","LU0708995583.HKD","CCS","IE0004086264.USD","LU0051755006.USD","LU0326950275.SGD","LU0516422952.EUR","BK4121","LU0516422366.SGD","BK1141","LU0742534661.SGD","BK1521","IE0004091025.USD","LU2237443895.HKD","IE00B19Z3B42.SGD","BK4550","IE00B19Z3581.USD","ADC","BK1576","BK4585","BK4588","LU1688375341.USD","LU0307460666.USD","IE00B0JY6N72.USD","WXXWY","PFS","LU0061475181.USD","BK4080","LU0039217434.USD","BK4231","LU1668664300.SGD","BK4088","02269","LU2237438978.USD","LU1242518857.USD","LU0588546209.SGD","LU0140636845.USD","LU0979878070.USD","LU0456846285.SGD","LU0251142724.SGD","BK4504","LU0417516902.SGD","IE00BSNM7G36.USD","LU0320764599.SGD","LU1242518931.SGD","LU0516422440.USD","LU0181495838.USD"],"gpt_icon":1},{"id":"2527984976","title":"火爆！18A最大IPO誕生！映恩生物創ADC港股神話","url":"https://stock-news.laohu8.com/highlight/detail?id=2527984976","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527984976?lang=zh_tw&edition=fundamental","pubTime":"2025-04-14 12:21","pubTimestamp":1744604460,"startTime":"0","endTime":"0","summary":"创近4年最大18A上市案例。同时，2025年医疗板块估值修复，港股18A企业平均股价涨幅翻倍，资本对ADC赛道的押注从谨慎转向狂热。ADC赛道进入价值重估阶段尽管IPO表现亮眼，映恩生物仍面临商业化与资金链考验。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-04-14/doc-inetccsy8932121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HSTECH","BK4614","ADC","BK4231","YANG","BK4080","09606"],"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADC\",params:#limit:5,,,undefined,":[{"date":"2025-04-30","symbol":"ADC","amount":0.256,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-30","defaultRemindTime":1746019800000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-14","payableDate":"2025-04-30","currency":"USD","dateTimestamp":1745985600000,"payDate":"2025-05-14"},{"date":"2025-04-22","symbol":"ADC","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":1.04,"defaultRemindTime":1745352000000,"name":null,"time":"盤後","dateTimestamp":1745294400000,"actualEps":null},{"date":"2025-03-31","symbol":"ADC","amount":0.253,"announcedDate":"2025-03-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-31","defaultRemindTime":1743427800000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-14","payableDate":"2025-03-31","currency":"USD","dateTimestamp":1743393600000,"payDate":"2025-04-14"},{"date":"2025-02-28","symbol":"ADC","amount":0.253,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-28","defaultRemindTime":1740753000000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-14","payableDate":"2025-02-28","currency":"USD","dateTimestamp":1740718800000,"payDate":"2025-03-14"},{"market":"US","date":"2025-02-11","symbol":"ADC","fiscalQuarterEnding":"2024/12","expectedEps":1.03,"name":null,"time":"盤後","type":"earning","dateTimestamp":1739250000000,"reportTimeType":"post","actualEps":1.04}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADC\",market:\"US\",,,undefined,":[{"executeDate":"2015-06-26","recordDate":"2015-06-30","paymentDate":"2015-07-14","value":0.465,"currency":"USD"},{"executeDate":"2015-09-28","recordDate":"2015-09-30","paymentDate":"2015-10-13","value":0.465,"currency":"USD"},{"executeDate":"2015-12-18","recordDate":"2015-12-22","paymentDate":"2016-01-05","value":0.465,"currency":"USD"},{"executeDate":"2016-03-29","recordDate":"2016-03-31","paymentDate":"2016-04-15","value":0.465,"currency":"USD"},{"executeDate":"2016-06-28","recordDate":"2016-06-30","paymentDate":"2016-07-15","value":0.48,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.4286,"hold":0.2381,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4286,"analysts":21,"updateTime":1741147200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADC","date":"2025-04-17","current":44.145605,"percent":0.782927,"low":31.539495,"twenty":37.540692,"median":40.519212,"eighty":44.559412,"high":53.261716,"avg":41.039364,"sd":4.458043,"marketCap":8352216066},"quantilePoints":[{"date":"2020-04-24","current":39.571166,"twenty":29.734763,"median":35.066723,"eighty":42.645471,"marketCap":3282942645},{"date":"2020-05-01","current":40.762794,"twenty":29.780108,"median":35.072974,"eighty":42.650816,"marketCap":3381803679},{"date":"2020-05-08","current":42.208376,"twenty":29.905766,"median":35.181944,"eighty":42.650816,"marketCap":3501733458},{"date":"2020-05-15","current":38.744189,"twenty":30.011559,"median":35.230489,"eighty":42.650816,"marketCap":3214334168},{"date":"2020-05-22","current":40.411166,"twenty":30.07119,"median":35.305025,"eighty":42.650816,"marketCap":3352631571},{"date":"2020-05-29","current":40.87144,"twenty":30.127131,"median":35.446997,"eighty":42.650816,"marketCap":3390817259},{"date":"2020-06-05","current":44.67404,"twenty":30.209273,"median":35.585113,"eighty":42.788104,"marketCap":3706292371},{"date":"2020-06-12","current":43.306667,"twenty":30.259415,"median":35.631973,"eighty":42.882133,"marketCap":3592850978},{"date":"2020-06-19","current":43.938263,"twenty":30.399208,"median":35.674606,"eighty":42.926676,"marketCap":3645250098},{"date":"2020-06-26","current":40.969109,"twenty":30.470777,"median":35.744304,"eighty":42.989446,"marketCap":3398920216},{"date":"2020-07-02","current":43.619209,"twenty":30.497525,"median":35.833506,"eighty":43.024146,"marketCap":3618780439},{"date":"2020-07-10","current":41.587683,"twenty":30.543737,"median":35.93098,"eighty":43.037844,"marketCap":3450238941},{"date":"2020-07-17","current":42.77274,"twenty":30.603622,"median":36.099734,"eighty":43.037844,"marketCap":3548554815},{"date":"2020-07-24","current":37.537078,"twenty":30.71291,"median":36.149452,"eighty":43.037844,"marketCap":3365424257},{"date":"2020-07-31","current":40.350852,"twenty":30.745133,"median":36.199495,"eighty":43.037844,"marketCap":3617696027},{"date":"2020-08-07","current":41.351038,"twenty":30.776927,"median":36.250246,"eighty":43.037844,"marketCap":3707368648},{"date":"2020-08-14","current":40.224323,"twenty":30.922362,"median":36.348523,"eighty":43.037844,"marketCap":3606351900},{"date":"2020-08-21","current":40.308676,"twenty":31.08368,"median":36.544296,"eighty":43.037844,"marketCap":3613914651},{"date":"2020-08-28","current":40.628012,"twenty":31.203975,"median":36.640352,"eighty":43.037844,"marketCap":3642545066},{"date":"2020-09-04","current":40.013441,"twenty":31.296906,"median":36.781594,"eighty":43.037844,"marketCap":3587445022},{"date":"2020-09-11","current":40.079718,"twenty":31.383772,"median":36.974643,"eighty":43.037844,"marketCap":3593387184},{"date":"2020-09-18","current":38.59149,"twenty":31.509762,"median":37.052903,"eighty":43.037844,"marketCap":3459958646},{"date":"2020-09-25","current":37.645532,"twenty":31.534039,"median":37.273263,"eighty":43.037844,"marketCap":3375147794},{"date":"2020-10-02","current":39.29644,"twenty":31.704694,"median":37.362034,"eighty":43.037844,"marketCap":3523161638},{"date":"2020-10-09","current":40.368928,"twenty":31.803276,"median":37.497873,"eighty":43.037844,"marketCap":3619316617},{"date":"2020-10-16","current":39.386818,"twenty":31.867808,"median":37.57347,"eighty":43.037844,"marketCap":3531264585},{"date":"2020-10-23","current":40.224079,"twenty":31.975443,"median":37.612137,"eighty":43.037844,"marketCap":3633239960},{"date":"2020-10-30","current":38.164301,"twenty":31.975443,"median":37.733323,"eighty":43.037844,"marketCap":3447190528},{"date":"2020-11-06","current":38.797606,"twenty":31.975443,"median":37.935059,"eighty":43.037844,"marketCap":3504393786},{"date":"2020-11-13","current":41.26934,"twenty":31.975443,"median":38.046028,"eighty":43.037844,"marketCap":3727653105},{"date":"2020-11-20","current":40.039622,"twenty":31.975443,"median":38.167733,"eighty":43.037844,"marketCap":3616578817},{"date":"2020-11-27","current":40.506914,"twenty":31.975443,"median":38.310136,"eighty":43.037844,"marketCap":3658787046},{"date":"2020-12-04","current":40.580698,"twenty":31.975443,"median":38.471704,"eighty":43.037844,"marketCap":3665451504},{"date":"2020-12-11","current":40.230228,"twenty":31.975443,"median":38.545534,"eighty":43.037844,"marketCap":3633795331},{"date":"2020-12-18","current":39.344831,"twenty":31.975443,"median":38.676992,"eighty":43.037844,"marketCap":3553821844},{"date":"2020-12-24","current":39.762935,"twenty":31.975443,"median":38.782235,"eighty":43.037844,"marketCap":3591587102},{"date":"2020-12-31","current":40.937316,"twenty":31.975443,"median":38.892751,"eighty":43.037844,"marketCap":3697663047},{"date":"2021-01-08","current":45.450661,"twenty":31.975443,"median":39.008592,"eighty":43.047885,"marketCap":4105330986},{"date":"2021-01-15","current":44.653159,"twenty":31.975443,"median":39.245492,"eighty":43.22631,"marketCap":4033296550},{"date":"2021-01-22","current":45.359718,"twenty":31.975443,"median":39.341757,"eighty":43.313411,"marketCap":4097116533},{"date":"2021-01-29","current":44.212433,"twenty":31.975443,"median":39.41667,"eighty":43.4163,"marketCap":3993488046},{"date":"2021-02-05","current":46.262155,"twenty":31.975443,"median":39.41667,"eighty":43.554978,"marketCap":4178629185},{"date":"2021-02-12","current":45.520618,"twenty":31.975443,"median":39.41667,"eighty":43.618647,"marketCap":4111649797},{"date":"2021-02-19","current":43.859591,"twenty":31.975443,"median":39.41667,"eighty":43.642628,"marketCap":4007933303},{"date":"2021-02-26","current":44.718497,"twenty":31.977009,"median":39.430911,"eighty":43.756513,"marketCap":4086420942},{"date":"2021-03-05","current":44.656157,"twenty":31.975443,"median":39.41667,"eighty":43.796506,"marketCap":4080724259},{"date":"2021-03-12","current":46.594043,"twenty":31.975443,"median":39.41667,"eighty":43.856021,"marketCap":4257810284},{"date":"2021-03-19","current":46.240217,"twenty":31.975443,"median":39.41667,"eighty":43.889974,"marketCap":4225477299},{"date":"2021-03-26","current":46.69811,"twenty":31.977009,"median":39.430911,"eighty":43.995818,"marketCap":4267319985},{"date":"2021-04-01","current":47.239256,"twenty":31.977009,"median":39.430911,"eighty":44.083322,"marketCap":4316770432},{"date":"2021-04-09","current":47.1005,"twenty":31.975443,"median":39.41667,"eighty":44.146464,"marketCap":4304090831},{"date":"2021-04-16","current":47.627771,"twenty":31.975443,"median":39.41667,"eighty":44.201737,"marketCap":4352273317},{"date":"2021-04-23","current":49.334461,"twenty":31.975443,"median":39.41667,"eighty":44.216631,"marketCap":4508232419},{"date":"2021-04-30","current":48.814129,"twenty":31.975443,"median":39.41667,"eighty":44.274005,"marketCap":4460683913},{"date":"2021-05-07","current":44.881383,"twenty":31.975443,"median":39.41667,"eighty":44.314742,"marketCap":4499986938},{"date":"2021-05-14","current":44.377456,"twenty":31.975443,"median":39.41667,"eighty":44.249425,"marketCap":4449461218},{"date":"2021-05-21","current":44.026621,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4414285084},{"date":"2021-05-28","current":44.830352,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4494870410},{"date":"2021-06-04","current":45.665977,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4578653566},{"date":"2021-06-11","current":45.646841,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4576734868},{"date":"2021-06-18","current":47.246871,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4737160278},{"date":"2021-06-25","current":48.748389,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4887708512},{"date":"2021-07-02","current":48.211648,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4833892628},{"date":"2021-07-09","current":49.210395,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4934031046},{"date":"2021-07-16","current":49.93058,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":5006239701},{"date":"2021-07-23","current":50.956505,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":5109102975},{"date":"2021-07-30","current":53.056971,"twenty":31.977009,"median":39.430911,"eighty":44.230599,"marketCap":5165308396},{"date":"2021-08-06","current":52.598062,"twenty":31.977009,"median":39.430911,"eighty":44.296692,"marketCap":5120631744},{"date":"2021-08-13","current":52.520401,"twenty":31.977009,"median":39.430911,"eighty":44.412506,"marketCap":5113071079},{"date":"2021-08-20","current":52.718085,"twenty":31.977009,"median":39.430911,"eighty":44.625208,"marketCap":5132316407},{"date":"2021-08-27","current":52.209754,"twenty":31.977009,"median":39.430911,"eighty":44.658936,"marketCap":5082828422},{"date":"2021-09-03","current":52.675724,"twenty":31.977009,"median":39.430911,"eighty":44.712504,"marketCap":5128192408},{"date":"2021-09-10","current":49.555141,"twenty":31.977009,"median":39.430911,"eighty":44.74795,"marketCap":4824391169},{"date":"2021-09-17","current":50.119952,"twenty":31.977009,"median":39.430911,"eighty":44.835833,"marketCap":4879377818},{"date":"2021-09-24","current":47.775985,"twenty":31.977009,"median":39.430911,"eighty":44.888065,"marketCap":4651183223},{"date":"2021-10-01","current":47.352376,"twenty":31.977009,"median":39.430911,"eighty":44.941549,"marketCap":4609943235},{"date":"2021-10-08","current":47.670083,"twenty":31.977009,"median":39.430911,"eighty":44.9864,"marketCap":4640873226},{"date":"2021-10-15","current":49.02563,"twenty":31.977009,"median":39.430911,"eighty":45.094688,"marketCap":4772841185},{"date":"2021-10-22","current":49.5269,"twenty":31.977009,"median":39.430911,"eighty":45.190701,"marketCap":4821641836},{"date":"2021-10-29","current":50.169373,"twenty":32.013133,"median":39.571166,"eighty":45.28245,"marketCap":4884189150},{"date":"2021-11-05","current":43.773853,"twenty":32.013133,"median":39.651928,"eighty":45.28245,"marketCap":4934976633},{"date":"2021-11-12","current":43.137928,"twenty":32.029424,"median":39.72736,"eighty":45.28245,"marketCap":4863283742},{"date":"2021-11-19","current":43.008274,"twenty":32.198132,"median":39.802558,"eighty":45.28245,"marketCap":4848666745},{"date":"2021-11-26","current":42.662528,"twenty":32.27459,"median":39.842867,"eighty":45.28245,"marketCap":4809688086},{"date":"2021-12-03","current":42.508177,"twenty":32.348817,"median":39.911012,"eighty":45.28245,"marketCap":4792286899},{"date":"2021-12-10","current":42.891493,"twenty":32.447032,"median":39.953188,"eighty":45.28245,"marketCap":4835501148},{"date":"2021-12-17","current":45.380751,"twenty":32.521786,"median":39.996581,"eighty":45.380751,"marketCap":5116135105},{"date":"2021-12-23","current":46.352906,"twenty":32.588031,"median":40.079057,"eighty":45.406143,"marketCap":5225733953},{"date":"2021-12-31","current":48.175698,"twenty":32.64443,"median":40.10618,"eighty":45.47788,"marketCap":5431231792},{"date":"2022-01-07","current":46.703962,"twenty":32.651599,"median":40.164071,"eighty":45.565296,"marketCap":5265311314},{"date":"2022-01-14","current":46.015352,"twenty":32.70478,"median":40.208708,"eighty":45.667046,"marketCap":5187678797},{"date":"2022-01-21","current":43.267663,"twenty":32.731462,"median":40.224323,"eighty":45.667046,"marketCap":4877909831},{"date":"2022-01-28","current":43.821252,"twenty":32.743358,"median":40.249944,"eighty":45.667046,"marketCap":4940320287},{"date":"2022-02-04","current":42.666817,"twenty":32.769192,"median":40.314701,"eighty":45.667046,"marketCap":4810171655},{"date":"2022-02-11","current":42.565551,"twenty":32.769192,"median":40.347561,"eighty":45.667046,"marketCap":4798755108},{"date":"2022-02-18","current":42.943612,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4841376882},{"date":"2022-02-25","current":37.784604,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4620036905},{"date":"2022-03-04","current":38.267307,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4679058463},{"date":"2022-03-11","current":37.29027,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4559593141},{"date":"2022-03-18","current":37.24956,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4554615419},{"date":"2022-03-25","current":38.110019,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4659826391},{"date":"2022-04-01","current":39.298046,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4805089927},{"date":"2022-04-08","current":39.763938,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4862056020},{"date":"2022-04-14","current":40.742313,"twenty":32.769192,"median":40.404479,"eighty":45.667046,"marketCap":4981684815},{"date":"2022-04-22","current":42.01187,"twenty":32.769192,"median":40.455317,"eighty":45.667046,"marketCap":5136917418},{"date":"2022-04-29","current":39.554287,"twenty":32.79826,"median":40.479695,"eighty":45.667046,"marketCap":4836421278},{"date":"2022-05-06","current":39.499614,"twenty":32.904642,"median":40.479695,"eighty":45.667046,"marketCap":5066773466},{"date":"2022-05-13","current":39.967203,"twenty":32.996397,"median":40.479695,"eighty":45.667046,"marketCap":5126753027},{"date":"2022-05-20","current":39.90291,"twenty":33.05702,"median":40.479695,"eighty":45.667046,"marketCap":5118505838},{"date":"2022-05-27","current":40.353768,"twenty":33.088236,"median":40.495181,"eighty":45.667046,"marketCap":5176339242},{"date":"2022-06-03","current":40.599257,"twenty":33.156377,"median":40.53176,"eighty":45.667046,"marketCap":5207829139},{"date":"2022-06-10","current":41.119461,"twenty":33.227354,"median":40.613635,"eighty":45.667046,"marketCap":5274557730},{"date":"2022-06-17","current":40.213488,"twenty":33.270165,"median":40.613635,"eighty":45.667046,"marketCap":5158345016},{"date":"2022-06-24","current":43.32302,"twenty":33.260026,"median":40.659236,"eighty":45.668114,"marketCap":5557217043},{"date":"2022-07-01","current":42.978166,"twenty":33.330747,"median":40.684242,"eighty":45.668114,"marketCap":5512981235},{"date":"2022-07-08","current":42.872956,"twenty":33.466784,"median":40.715658,"eighty":45.668114,"marketCap":5499485565},{"date":"2022-07-15","current":43.708789,"twenty":33.59929,"median":40.742313,"eighty":45.668114,"marketCap":5606701167},{"date":"2022-07-22","current":44.556311,"twenty":33.59929,"median":40.778643,"eighty":45.668114,"marketCap":5715416287},{"date":"2022-07-29","current":46.520226,"twenty":33.675236,"median":40.820493,"eighty":45.678143,"marketCap":5967335462},{"date":"2022-08-05","current":43.100932,"twenty":33.675236,"median":40.862996,"eighty":45.68777,"marketCap":6116022220},{"date":"2022-08-12","current":44.318758,"twenty":33.675236,"median":40.912721,"eighty":45.68777,"marketCap":6288831702},{"date":"2022-08-19","current":44.509569,"twenty":33.675236,"median":40.969109,"eighty":45.68777,"marketCap":6315907842},{"date":"2022-08-26","current":43.241234,"twenty":33.675236,"median":41.010201,"eighty":45.68777,"marketCap":6135931147},{"date":"2022-09-02","current":41.585665,"twenty":33.675236,"median":41.060268,"eighty":45.68777,"marketCap":5901005814},{"date":"2022-09-09","current":41.956063,"twenty":33.675236,"median":41.092655,"eighty":45.68777,"marketCap":5953565380},{"date":"2022-09-16","current":40.805583,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5790312183},{"date":"2022-09-23","current":39.935707,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5666876838},{"date":"2022-09-30","current":37.927001,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5381841428},{"date":"2022-10-07","current":36.428553,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5169211706},{"date":"2022-10-14","current":35.631626,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5056127734},{"date":"2022-10-21","current":36.636203,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5198677248},{"date":"2022-10-28","current":38.359137,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5443161610},{"date":"2022-11-04","current":41.724424,"twenty":33.675236,"median":41.119461,"eighty":45.68777,"marketCap":6035896875},{"date":"2022-11-11","current":42.347632,"twenty":33.675236,"median":41.160749,"eighty":45.68777,"marketCap":6126050848},{"date":"2022-11-18","current":42.756995,"twenty":33.675236,"median":41.197005,"eighty":45.68777,"marketCap":6185269635},{"date":"2022-11-25","current":43.056379,"twenty":33.675236,"median":41.218321,"eighty":45.68777,"marketCap":6228578896},{"date":"2022-12-02","current":43.196907,"twenty":33.675236,"median":41.257018,"eighty":45.68777,"marketCap":6248907733},{"date":"2022-12-09","current":43.795676,"twenty":33.675236,"median":41.35326,"eighty":45.68777,"marketCap":6335526256},{"date":"2022-12-16","current":43.172467,"twenty":33.675236,"median":41.423201,"eighty":45.68777,"marketCap":6245372283},{"date":"2022-12-23","current":43.685698,"twenty":33.675236,"median":41.463369,"eighty":45.68777,"marketCap":6319616732},{"date":"2022-12-30","current":43.337434,"twenty":33.675236,"median":41.483593,"eighty":45.68777,"marketCap":6269236570},{"date":"2023-01-06","current":43.245786,"twenty":34.167053,"median":41.539601,"eighty":45.68777,"marketCap":6255978633},{"date":"2023-01-13","current":45.714181,"twenty":34.992765,"median":41.587683,"eighty":45.704396,"marketCap":6613059075},{"date":"2023-01-20","current":45.402576,"twenty":35.880519,"median":41.605991,"eighty":45.714503,"marketCap":6567982088},{"date":"2023-01-27","current":45.378137,"twenty":36.169649,"median":41.646285,"eighty":45.714503,"marketCap":6564446638},{"date":"2023-02-03","current":45.255939,"twenty":36.592515,"median":41.674422,"eighty":45.714503,"marketCap":6546769389},{"date":"2023-02-10","current":44.406665,"twenty":36.713651,"median":41.711398,"eighty":45.714503,"marketCap":6423912504},{"date":"2023-02-17","current":44.157808,"twenty":36.89773,"median":41.739833,"eighty":45.714503,"marketCap":6731283715},{"date":"2023-02-24","current":42.410386,"twenty":36.963658,"median":41.754028,"eighty":45.714503,"marketCap":6464912060},{"date":"2023-03-03","current":41.690165,"twenty":37.214665,"median":41.783816,"eighty":45.714503,"marketCap":6355123742},{"date":"2023-03-10","current":39.423241,"twenty":37.286636,"median":41.783816,"eighty":45.714503,"marketCap":6009560514},{"date":"2023-03-17","current":40.355986,"twenty":37.342014,"median":41.783816,"eighty":45.714503,"marketCap":6151745384},{"date":"2023-03-24","current":39.606247,"twenty":37.466803,"median":41.783816,"eighty":45.714503,"marketCap":6037457546},{"date":"2023-03-31","current":40.621801,"twenty":37.536428,"median":41.78137,"eighty":45.714342,"marketCap":6192265465},{"date":"2023-04-06","current":39.692254,"twenty":37.577737,"median":41.783816,"eighty":45.714503,"marketCap":6050568092},{"date":"2023-04-14","current":39.289647,"twenty":37.687654,"median":41.784219,"eighty":45.714663,"marketCap":5989195981},{"date":"2023-04-21","current":39.792905,"twenty":37.872566,"median":41.784621,"eighty":45.714824,"marketCap":6065911119},{"date":"2023-04-28","current":40.118543,"twenty":37.943837,"median":41.797292,"eighty":45.714985,"marketCap":6115550327},{"date":"2023-05-05","current":39.964605,"twenty":38.110019,"median":41.797292,"eighty":45.714985,"marketCap":6092084520},{"date":"2023-05-12","current":39.104119,"twenty":38.249787,"median":41.797292,"eighty":45.714985,"marketCap":6176026400},{"date":"2023-05-19","current":38.898029,"twenty":38.342909,"median":41.797292,"eighty":45.714985,"marketCap":6143476946},{"date":"2023-05-26","current":37.796919,"twenty":38.456408,"median":41.797292,"eighty":45.714985,"marketCap":5969569863},{"date":"2023-06-02","current":37.832249,"twenty":38.456408,"median":41.797292,"eighty":45.714985,"marketCap":5975149770},{"date":"2023-06-09","current":38.668386,"twenty":38.476762,"median":41.797292,"eighty":45.714985,"marketCap":6107207554},{"date":"2023-06-16","current":38.786152,"twenty":38.533217,"median":41.797292,"eighty":45.714985,"marketCap":6125807242},{"date":"2023-06-23","current":38.509402,"twenty":38.553397,"median":41.809962,"eighty":45.718688,"marketCap":6082097976},{"date":"2023-06-30","current":38.55062,"twenty":38.5799,"median":41.81327,"eighty":45.72239,"marketCap":6088607866},{"date":"2023-07-07","current":38.662498,"twenty":38.628346,"median":41.81327,"eighty":45.72239,"marketCap":6106277570},{"date":"2023-07-14","current":38.603615,"twenty":38.628346,"median":41.81327,"eighty":45.72239,"marketCap":6096977726},{"date":"2023-07-21","current":39.357316,"twenty":38.659115,"median":41.81327,"eighty":45.72239,"marketCap":6216015729},{"date":"2023-07-28","current":39.404422,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6223455604},{"date":"2023-08-04","current":38.053978,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6196443469},{"date":"2023-08-11","current":37.511193,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6108060089},{"date":"2023-08-18","current":36.166029,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5889023018},{"date":"2023-08-25","current":36.531819,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5948585730},{"date":"2023-09-01","current":36.472821,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5938978841},{"date":"2023-09-08","current":35.75304,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5821774794},{"date":"2023-09-15","current":35.446248,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5771818971},{"date":"2023-09-22","current":33.711695,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5489376431},{"date":"2023-09-29","current":32.567126,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5303002783},{"date":"2023-10-06","current":32.649724,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5316452427},{"date":"2023-10-13","current":31.806046,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5179073913},{"date":"2023-10-20","current":32.41963,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5278985560},{"date":"2023-10-27","current":33.181375,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5472604212},{"date":"2023-11-03","current":35.377246,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5834769220},{"date":"2023-11-10","current":34.598655,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5706356142},{"date":"2023-11-17","current":35.425908,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5842795038},{"date":"2023-11-24","current":35.170433,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5800659496},{"date":"2023-12-01","current":36.015934,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5940108073},{"date":"2023-12-08","current":36.873602,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6081563104},{"date":"2023-12-15","current":37.7556,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6227031044},{"date":"2023-12-22","current":37.968496,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6262143995},{"date":"2023-12-29","current":38.607184,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":6367482847},{"date":"2024-01-05","current":38.296964,"twenty":38.756995,"median":41.871582,"eighty":45.73451,"marketCap":6316318262},{"date":"2024-01-12","current":38.090151,"twenty":38.758791,"median":41.871582,"eighty":45.73451,"marketCap":6282208538},{"date":"2024-01-19","current":36.989174,"twenty":38.764196,"median":41.872103,"eighty":45.735522,"marketCap":6100624420},{"date":"2024-01-26","current":36.295741,"twenty":38.758791,"median":41.871582,"eighty":45.73451,"marketCap":5986256523},{"date":"2024-02-02","current":37.232484,"twenty":38.697827,"median":41.871582,"eighty":45.73451,"marketCap":6140753507},{"date":"2024-02-09","current":35.261674,"twenty":38.661168,"median":41.871582,"eighty":45.73451,"marketCap":5815707904},{"date":"2024-02-16","current":33.847315,"twenty":38.629468,"median":41.871582,"eighty":45.73451,"marketCap":5752655855},{"date":"2024-02-23","current":33.670228,"twenty":38.597685,"median":41.871582,"eighty":45.73451,"marketCap":5722558249},{"date":"2024-03-01","current":32.436519,"twenty":38.556509,"median":41.871061,"eighty":45.733498,"marketCap":5512878257},{"date":"2024-03-08","current":33.758772,"twenty":38.535146,"median":41.871061,"eighty":45.733498,"marketCap":5737607052},{"date":"2024-03-15","current":32.6018,"twenty":38.489062,"median":41.871061,"eighty":45.733498,"marketCap":5540969356},{"date":"2024-03-22","current":33.262927,"twenty":38.456408,"median":41.871061,"eighty":45.733498,"marketCap":5653333754},{"date":"2024-03-28","current":33.457723,"twenty":38.385748,"median":41.784621,"eighty":45.733498,"marketCap":5686441121},{"date":"2024-04-05","current":33.192092,"twenty":38.338315,"median":41.766476,"eighty":45.73451,"marketCap":5641294711},{"date":"2024-04-12","current":33.499043,"twenty":38.271415,"median":41.746116,"eighty":45.73451,"marketCap":5693463896},{"date":"2024-04-19","current":32.99201,"twenty":38.226469,"median":41.73308,"eighty":45.73451,"marketCap":5607289064},{"date":"2024-04-26","current":33.647761,"twenty":38.150217,"median":41.720309,"eighty":45.733498,"marketCap":5827926731},{"date":"2024-05-03","current":33.618779,"twenty":38.090151,"median":41.711398,"eighty":45.733498,"marketCap":5822906984},{"date":"2024-05-10","current":34.482434,"twenty":38.029323,"median":41.69585,"eighty":45.733498,"marketCap":5972495456},{"date":"2024-05-17","current":34.986715,"twenty":37.950247,"median":41.66791,"eighty":45.733498,"marketCap":6059839061},{"date":"2024-05-24","current":34.198413,"twenty":37.871294,"median":41.619337,"eighty":45.733498,"marketCap":5923301932},{"date":"2024-05-31","current":34.928752,"twenty":37.820473,"median":41.602226,"eighty":45.733498,"marketCap":6049799566},{"date":"2024-06-07","current":35.908334,"twenty":37.7418,"median":41.585665,"eighty":45.733498,"marketCap":6219467028},{"date":"2024-06-14","current":35.311311,"twenty":37.642264,"median":41.478607,"eighty":45.73451,"marketCap":6116060232},{"date":"2024-06-21","current":35.485201,"twenty":37.563829,"median":41.447441,"eighty":45.735522,"marketCap":6146178716},{"date":"2024-06-28","current":35.734443,"twenty":37.537078,"median":41.447441,"eighty":45.738558,"marketCap":6189348544},{"date":"2024-07-05","current":35.879352,"twenty":37.482188,"median":41.447441,"eighty":45.738558,"marketCap":6214447281},{"date":"2024-07-12","current":36.957471,"twenty":37.418215,"median":41.439295,"eighty":45.738558,"marketCap":6401181884},{"date":"2024-07-15","current":37.189325,"twenty":37.412399,"median":41.439295,"eighty":45.738558,"marketCap":6441339863},{"date":"2024-08-02","current":37.993919,"twenty":37.339153,"median":41.40142,"eighty":45.707657,"marketCap":7107142493},{"date":"2024-08-09","current":38.417922,"twenty":37.339153,"median":41.351038,"eighty":45.669183,"marketCap":7186456557},{"date":"2024-08-16","current":38.455492,"twenty":37.339153,"median":41.248609,"eighty":45.587895,"marketCap":7193484385},{"date":"2024-08-23","current":38.879496,"twenty":37.339153,"median":41.197005,"eighty":45.51208,"marketCap":7272798449},{"date":"2024-08-30","current":39.104915,"twenty":37.339153,"median":41.152223,"eighty":45.432939,"marketCap":7314965420},{"date":"2024-09-06","current":40.19981,"twenty":37.339153,"median":41.109476,"eighty":45.406991,"marketCap":7519776420},{"date":"2024-09-13","current":40.725789,"twenty":37.339153,"median":41.060268,"eighty":45.379705,"marketCap":7618166018},{"date":"2024-09-20","current":39.786541,"twenty":37.339153,"median":41.020981,"eighty":45.296882,"marketCap":7442470307},{"date":"2024-09-27","current":39.931453,"twenty":37.339153,"median":40.992653,"eighty":45.271719,"marketCap":7469577645},{"date":"2024-10-04","current":40.355457,"twenty":37.339153,"median":40.937316,"eighty":45.211095,"marketCap":7548891709},{"date":"2024-10-11","current":39.3196,"twenty":37.339153,"median":40.894276,"eighty":45.159517,"marketCap":7355124439},{"date":"2024-10-18","current":40.731156,"twenty":37.339153,"median":40.838938,"eighty":45.089028,"marketCap":7619169993},{"date":"2024-10-25","current":42.532506,"twenty":37.339153,"median":40.820493,"eighty":45.046981,"marketCap":8077475775},{"date":"2024-10-31","current":40.816625,"twenty":37.339153,"median":40.816625,"eighty":44.988744,"marketCap":7751607762},{"date":"2024-11-08","current":40.076878,"twenty":37.338438,"median":40.773001,"eighty":44.942004,"marketCap":7611120201},{"date":"2024-11-15","current":41.115788,"twenty":37.338438,"median":40.773001,"eighty":44.942004,"marketCap":7808422584},{"date":"2024-11-22","current":41.948003,"twenty":37.338438,"median":40.773001,"eighty":44.914929,"marketCap":7966471090},{"date":"2024-11-29","current":41.773945,"twenty":37.338438,"median":40.773001,"eighty":44.914324,"marketCap":7933415193},{"date":"2024-12-06","current":40.849261,"twenty":37.338438,"median":40.770318,"eighty":44.892115,"marketCap":7757805742},{"date":"2024-12-13","current":40.055121,"twenty":37.338438,"median":40.736734,"eighty":44.892115,"marketCap":7606988214},{"date":"2024-12-20","current":37.770608,"twenty":37.338438,"median":40.680888,"eighty":44.892115,"marketCap":7173129570},{"date":"2024-12-27","current":38.515795,"twenty":37.338438,"median":40.640959,"eighty":44.892115,"marketCap":7314650128},{"date":"2025-01-03","current":37.933788,"twenty":37.338438,"median":40.614232,"eighty":44.892115,"marketCap":7204119473},{"date":"2025-01-10","current":37.906591,"twenty":37.337724,"median":40.580698,"eighty":44.89414,"marketCap":7198954490},{"date":"2025-01-17","current":39.244663,"twenty":37.333873,"median":40.538993,"eighty":44.89414,"marketCap":7453071695},{"date":"2025-01-24","current":38.87479,"twenty":37.333873,"median":40.501145,"eighty":44.89414,"marketCap":7382827915},{"date":"2025-01-31","current":39.761398,"twenty":37.333873,"median":40.465332,"eighty":44.84311,"marketCap":7551206388},{"date":"2025-02-07","current":39.74508,"twenty":37.333873,"median":40.424995,"eighty":44.718497,"marketCap":7548107398},{"date":"2025-02-14","current":40.634976,"twenty":37.333873,"median":40.403761,"eighty":44.67404,"marketCap":7688015540},{"date":"2025-02-21","current":40.363435,"twenty":37.333873,"median":40.374953,"eighty":44.653159,"marketCap":7636640801},{"date":"2025-02-28","current":41.687197,"twenty":37.333873,"median":40.374953,"eighty":44.559412,"marketCap":7887092651},{"date":"2025-03-07","current":42.394335,"twenty":37.33306,"median":40.37194,"eighty":44.562299,"marketCap":8020881032},{"date":"2025-03-14","current":42.767704,"twenty":37.33306,"median":40.383179,"eighty":44.562299,"marketCap":8091521298},{"date":"2025-03-21","current":43.141073,"twenty":37.417052,"median":40.40791,"eighty":44.562299,"marketCap":8162161563},{"date":"2025-03-28","current":42.993988,"twenty":37.479862,"median":40.452151,"eighty":44.562299,"marketCap":8134333580},{"date":"2025-04-04","current":43.440899,"twenty":37.536428,"median":40.487288,"eighty":44.562299,"marketCap":8218887836},{"date":"2025-04-11","current":41.268572,"twenty":37.537078,"median":40.501145,"eighty":44.559412,"marketCap":7807889929},{"date":"2025-04-17","current":44.145605,"twenty":37.540692,"median":40.519212,"eighty":44.559412,"marketCap":8352216066}],"updateTime":1745041838478}}}